Gts Securities LLC Ardelyx, Inc. Put Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$5.28 - $7.57 $96,624 - $138,531	-18,300 Reduced 24.8%	55,500 $382,000
Q2 2024 Aug 14, 2024	SELL	$5.89 - $9.31 $244,435 - $386,365	-41,500 Reduced 35.99%	73,800 $546,000
Q1 2024 May 15, 2024	BUY	$6.05 - $9.74 $226,875 - $365,250	37,500 Added 48.2%	115,300 $841,000
Q4 2023 Feb 14, 2024	BUY	$3.29 - $6.64 $162,855 - $328,680	49,500 Added 174.91%	77,800 $482,000
Q3 2023 Nov 15, 2023	BUY	$3.3 - $4.83 $93,390 - $136,689	28,300 New	28,300 $115,000

220

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $769M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.